The clinical impact of vehicle technology using a patented formulation of benzoyl peroxide 5%/clindamycin 1% gel: comparative assessments of skin tolerability and evaluation of combination use with a topical retinoid.

Journal of drugs in dermatology : JDD

Volumn 5, Issue 2, 2006, Pages 160-164

  Del Rosso, James Q ^a   Tanghetti, Emil ^a  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BENZOYL PEROXIDE; CLINDAMYCIN; CLINDAMYCIN PHOSPHATE; CLINDAMYCIN-2-PHOSPHATE; DRUG DERIVATIVE; DRUG VEHICLE; RETINOID;

ACNE VULGARIS; ADOLESCENT; ARTICLE; CHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG COMBINATION; DRUG EFFECT; EVALUATION; FEMALE; GEL; HUMAN; MULTICENTER STUDY; PATIENT SATISFACTION; RANDOMIZED CONTROLLED TRIAL; SKIN; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME; VEHICLES;

ACNE VULGARIS; ADMINISTRATION, TOPICAL; ADOLESCENT; ANTI-BACTERIAL AGENTS; BENZOYL PEROXIDE; CHEMISTRY, PHARMACEUTICAL; CLINDAMYCIN; DRUG COMBINATIONS; EVALUATION STUDIES; FEMALE; GELS; HUMANS; MULTICENTER STUDIES; PATIENT SATISFACTION; RANDOMIZED CONTROLLED TRIALS; RETINOIDS; SKIN; TREATMENT OUTCOME; VEHICLES;

EID: 33646168125     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)